These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15548573)

  • 41. alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition.
    Defilles C; Lissitzky JC; Montero MP; André F; Prévot C; Delamarre E; Marrakchi N; Luis J; Rigot V
    Exp Cell Res; 2009 Jul; 315(11):1840-9. PubMed ID: 19328197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases.
    Zöller M; Gupta P; Marhaba R; Vitacolonna M; Freyschmidt-Paul P
    J Leukoc Biol; 2007 Jul; 82(1):57-71. PubMed ID: 17442857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium.
    Sehnert B; Gierer P; Ibrahim S; Kühl A; Voll R; Nandakumar KS; Holmdahl R; Hallmann R; Vollmar B; Burkhardt H
    Arthritis Res Ther; 2006; 8(4):R95. PubMed ID: 16776851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and function of the leukocyte integrins in organ transplant rejection.
    Noti JD
    Curr Med Chem; 2004 Feb; 11(4):477-90. PubMed ID: 14965228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrin antagonists.
    Curley GP; Blum H; Humphries MJ
    Cell Mol Life Sci; 1999 Oct; 56(5-6):427-41. PubMed ID: 11212296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice.
    Gu YC; Bauer TR; Ackermann MR; Smith CW; Kehrli ME; Starost MF; Hickstein DD
    Comp Med; 2004 Aug; 54(4):363-72. PubMed ID: 15357315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Targeting and role of α4β7 integrin in the pathophysiology of IBD and HIV infection].
    Girard A; Rochereau N; Roblin X; Genin C; Paul S
    Med Sci (Paris); 2015 Oct; 31(10):895-903. PubMed ID: 26481029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The therapeutic potential of I-domain integrins.
    Brennan M; Cox D
    Adv Exp Med Biol; 2014; 819():157-78. PubMed ID: 25023174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy.
    Harlan JM; Winn RK
    Crit Care Med; 2002 May; 30(5 Suppl):S214-9. PubMed ID: 12004238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrin antagonists as therapeutics for inflammatory diseases.
    Vanderslice P; Woodside DG
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1235-55. PubMed ID: 16989599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease.
    Bamias G; Clark DJ; Rivera-Nieves J
    Curr Drug Targets; 2013 Nov; 14(12):1490-500. PubMed ID: 23621509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitors of membrane receptors involved with leukocyte extravasation.
    Bendas G
    Mini Rev Med Chem; 2005 Jun; 5(6):575-84. PubMed ID: 15974935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrins: Integrating the Biology and Therapy of Cell-cell Interactions.
    Pandolfi F; Franza L; Altamura S; Mandolini C; Cianci R; Ansari A; Kurnick JT
    Clin Ther; 2017 Dec; 39(12):2420-2436. PubMed ID: 29203050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukocyte integrins and their ligands: their possible role in the pathogenesis of pulmonary sarcoidosis.
    Melis M; Gjomarkaj M; Pace E; Merendino AM; Ghiappara G; Spatafora M; Bonsignore G
    Sarcoidosis; 1991 Sep; 8(2):172-4. PubMed ID: 1669987
    [No Abstract]   [Full Text] [Related]  

  • 55. Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.
    Wyatt NJ; Speight RA; Stewart CJ; Kirby JA; Lamb CA
    BioDrugs; 2021 Sep; 35(5):473-503. PubMed ID: 34613592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selectins-an emerging target for drug delivery.
    Ehrhardt C; Kneuer C; Bakowsky U
    Adv Drug Deliv Rev; 2004 Mar; 56(4):527-49. PubMed ID: 14969757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukocyte cell adhesion proteins: from molecular dissection to clinical applications.
    Gahmberg CG; Nortamo P; Li R; Valmu L
    Ann Med; 1992 Oct; 24(5):329-35. PubMed ID: 1418914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukocyte integrin activation.
    Hogg N; Bennett R; Cabañas C; Dransfield I
    Kidney Int; 1992 Mar; 41(3):613-6. PubMed ID: 1573838
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs, inflammation and cell adhesion receptors.
    Sánchez-Madrid F; González-Amaro R
    Expert Opin Pharmacother; 2001 Jan; 2(1):3-17. PubMed ID: 11336564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting T-cell integrins in autoimmune and inflammatory diseases.
    Kelly AJ; Long A
    Clin Exp Immunol; 2024 Jan; 215(1):15-26. PubMed ID: 37556361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.